Pharmacokinetics of high-dose methotrexate in infants aged less than 12 months treated for aggressive brain tumors

被引:0
|
作者
Maurizio Lucchesi
Milena Guidi
Carla Fonte
Silvia Farina
Patrizio Fiorini
Claudio Favre
Maurizio de Martino
Iacopo Sardi
机构
[1] Meyer Children’s University Hospital,Neuro
[2] Meyer Children’s University Hospital,Oncology Unit, Department of Pediatric Oncology
[3] University of Florence,Neonatal Intensive Care Unit, Department of Pediatrics
来源
关键词
High-dose methotrexate; Pediatric brain tumors; Early infants; Chemotherapy toxicities; Pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:857 / 864
页数:7
相关论文
共 50 条
  • [21] NORMAL COMPUTED TOMOGRAMS OF THE BRAIN IN OSTEO-SARCOMA PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE
    BOWLES, D
    PRATT, C
    EVANS, W
    PRICE, RA
    COBURN, T
    CANCER, 1981, 47 (07) : 1762 - 1765
  • [22] Factors Affecting the Upper Limit of the Methotrexate (MTX) CSF Levels Achievable in Children With Brain Tumors Treated With High-dose Intravenous MTX
    Zemer, Vered Shkalim
    Toledano, Helen
    Ash, Shifra
    Cohen, Eytan
    Yaniv, Isaac
    Cohen, Ian J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (07) : 544 - 548
  • [23] High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors
    Alsultan, Abdulrahman
    Alharbi, Musa
    Al-Dandan, Sadeq
    Bayoumi, Yasser
    Alharbi, Talal
    Alsudairy, Reem
    Alomari, Ali
    Aljamaan, Khalid
    Musleh, Othman
    Alharbi, Qasim
    Jarrar, Mohammed
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) : 204 - 208
  • [24] PRERADIATION HIGH-DOSE INTRAVENOUS METHOTREXATE WITH LEUCOVORIN RESCUE FOR UNTREATED PRIMARY CHILDHOOD BRAIN-TUMORS
    ALLEN, JC
    WALKER, R
    ROSEN, G
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) : 649 - 653
  • [25] Less Than Half of Patients Treated with High-Dose Allopurinol Reach Serum Uric Acid Target
    Morlock, Robert
    Taylor, Douglas C. A.
    Baumgartner, Scott
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] OSTEOGENIC-SARCOMA - MR SIGNAL ABNORMALITIES OF THE BRAIN IN ASYMPTOMATIC PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE
    LIEN, HH
    BLOMLIE, V
    SAETER, G
    SOLHEIM, O
    FOSSA, SD
    RADIOLOGY, 1991, 179 (02) : 547 - 550
  • [27] TANDEM HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INFANTS WITH EMBRYONAL BRAIN TUMORS
    Gevorgian, Asmik
    Tolkunova, Polina
    Iukhta, Tatiana
    Morozova, Elena
    Kazantsev, Ilya
    Andreeva, Tatiana
    Kozlov, Andrew
    Safonova, Svetlana
    Punanov, Yury
    Zubarovskaya, Ludmila
    Zheludkova, Olga
    Afanasyev, Boris
    NEURO-ONCOLOGY, 2018, 20 : 70 - 71
  • [28] AN ANALYSIS OF THE PHARMACOKINETICS AND TOXICITY OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH HISTOLOGICALLY AGGRESSIVE NON-HODGKIN LYMPHOMA AT HIGH RISK OF CENTRAL NERVOUS SYSTEM DISEASE
    Ninkovic, S.
    Cheah, C. Y.
    Tatarczuch, M.
    Burbury, K. L.
    Quach, H.
    Seymour, J. F.
    Harrison, S. J.
    HAEMATOLOGICA, 2014, 99 : 702 - 702
  • [29] A case of prospective use of carboksypeptidase G2 rescue for brain lymphoma treated with high-dose methotrexate
    Mrugala, MM
    Kolak, G
    Oneill, AM
    Wideman, B
    Hochberg, FH
    NEUROLOGY, 2006, 66 (05) : A337 - A337
  • [30] A QUANTITATIVE ANALYSIS OF BRAIN VOLUME DYNAMICS IN PCNSL PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE-BASED THERAPY
    Sivakumar, Ananyaa
    Kamson, David
    Estephan, Fayez
    Lambrecht, Sebastian
    Dzaye, Omar
    Wagner-Johnston, Nina
    Swinnen, Lode
    Gladstone, Douglas
    Lin, Doris
    Grossman, Stuart
    Holdhoff, Matthias
    NEURO-ONCOLOGY, 2020, 22 : 160 - 160